±ÒÓιú¼Ê¹ÙÍø

Ê×Ò³
×ß½ø±ÒÓιú¼Ê¹ÙÍø
ÆóÒµ¼ò½é
ÎÄ»¯ÀíÄî
ÀúÊ·ÑØ¸ï
×éÖ¯¼Ü¹¹
ÆóÒµ¸èÇú
ÆóÒµÉùÓþ
²úÆ·Óë·þÎñ
²úÆ·
·þÎñ
Á¢Òì
¶¯Ì¬×ÊѶ
ÐÂÎÅ×ÊѶ
Éç»áÔðÈÎ
Ͷ×ÊÕß¹ØÏµ
¹«Ë¾Í¨¸æ
Ͷ×ÊÕß½ÌÓý
¹ÉƱÐÐÇé
ÁªÏµ±ÒÓιú¼Ê¹ÙÍø
×îпÆÑÐЧ¹û£º¹ÇËè¼ä³äÖʸÉϸ°û¿ÉÒÔÏÔÖø¸ÄÉÆ×Ô±Õ֢СÊóÐÐΪȱÏÝ
ȪԴ£º±ÒÓιú¼Ê¹ÙÍø¼¯ÍÅ Ðû²¼Ê±¼ä£º2023Äê12ÔÂ04ÈÕ ÖÖ±ð£ºÐÂÎÅ×ÊѶ

      2023Äê12ÔÂ3ÈÕ£¬±ÒÓιú¼Ê¹ÙÍøÃÀ¿ÆÊ¹ÓÃÈ˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁÆ×Ô±ÕÖ¢µÄÁÙ´²Ç°Ò©Ð§Ñ§Ñо¿ÂÛÎÄ¡¶Intravenous transplantation of bone marrow-derived mesenchymal stem cells improved behavioral deficits and altered fecal microbiota composition of BTBR mice¡·£¨¹ÇËè¼ä³äÖʸÉϸ°û¾²ÂöÒÆÖ²¸ÄÉÆBTBRСÊóµÄÐÐΪȱÏݲ¢¾ÀÕýÆä·à±ã΢ÉúÎïȺ×é³É£©£¬ÒѾ­Õýʽ±»¹ú¼Ê×ÅÃûѧÊõÆÚ¿¯¡¶Life Sciences¡·ÎüÊÕ²¢½ÒÏþ¡£

undefined

      ¸ÃÂÛÎÄÔËÓÃÏèʵµÄÊý¾Ý£¬³ä·Ö֤ʵÁËÈ˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁÆ×Ô±Õ֢ģ×Ó¶¯ÎïµÄÓÐÓÃÐÔ£¬²¢ÔÚ¹ú¼ÊÉÏÊ×´ÎÌá³öÁ˸Éϸ°ûÖÎÁƹØÓÚ×Ô±Õ֢ģ×Ó¶¯ÎﳦµÀ¾úȺµÄÓ°Ïì¡£ÕâҲԤʾןÉϸ°û»òÔÚÖÎÁÆ×Ô±ÕÖ¢·½Ãæ±£´æÖش󿪷¢Ç±Á¦¡£


      ×Ô±ÕÖ¢Æ×ϵÕϰ­(Autism Spectrum Disorder,ASD)£¬Óֳƹ¿àÖ¢£¬ÊÇÒ»Öָ߶ÈÖØ´óµÄÉñ¾­·¢ÓýÕϰ­ÐÔ¼²²¡¡£¸Ã¼²²¡Æð²¡ÓÚÓ¤Ó×¶ùʱÆÚ£¬ÒÔÉç»áÀ´ÍùÕϰ­¡¢½»Á÷Õϰ­¡¢¾ÖÏÞÐËȤ¡¢¿Ì°åÓëÖØ¸´ÐÐΪ·½·¨ÎªÖ÷ÒªÁÙ´²ÌåÏÖ£¬´ó¶¼»¼¶ù»¹»á°éÓвî±ðˮƽµÄ¾«Éñ·¢Óý³ÙÖÍ¡£¾Ýͳ¼Æ£¬ÎÒ¹úÏÖÔÚԼĪÓÐ1300Íò×Ô±ÕÖ¢»¼¶ù£¬Æ½¾ùÿ100¸öº¢×ÓÖоÍÓÐÒ»¸ö×Ô±ÕÖ¢£¬È«ÇòÏÖÔÚ×Ô±ÕÖ¢»¼¶ùÒѾ­Áè¼Ý6700Íò¡£ÏÖÔÚÕë¶Ô×Ô±ÕÖ¢ÉÐÎÞÃ÷È·µÄÖÎÁÆÒªÁ죬ÊôÓÚδ±»Öª×ãµÄÒ½ÁÆÐèÇ󣬯ÈÇÐÐèÒªÕÒµ½ÐµÄÖÎÁÆÕ½ÂÔ¡£


      ±ÒÓιú¼Ê¹ÙÍøÃÀ¿ÆµÄÁÙ´²ÍŶÓ£¬Í¨¹ý¶à¸öʱ¼äµãµÄ¿õ³¡(open field test£¬OFT)¡¢Ã÷°µÏ䣨light-dark box test£¬LDT£©¡¢ÐÂÎïÌåʶ±ð(novel object recognition,NOR)¡¢×ÔÓÉÉç½»(free social test,FST)¡¢¿Ì°åÐÐΪ(stereotypic behavior,SB)µÈһϵÁÐÐÐΪѧÊÔÑ飨ͼ1¡¢2¡¢3£©£¬·¢Ã÷ÁËÈ˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©¾²ÂöÖÎÁÆ¿ÉÓÐÓûº½âÁËBTBRСÊóµÄ×Ô±ÕÖ¢ÑùÖ¢×´£¬Ö÷ÒªÌåÏÖΪÔ˶¯¡¢½¹ÂÇÐÐΪ¼°¿Ì°åÐÐΪµÄïÔÌ­£¬Éç»áȱÏݵĵ÷½âµÈ¡£

undefined

£¨Í¼1£©

 

      ͼ1£¬È˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁƿɸıäBTBRСÊóµÄ½¹ÂǺÍ̽Ë÷ÐÔÔ˶¯¡£A.¿õ³¡ÊµÑ鼯»®¡£B.¿õ³¡ÊÔÑéÖÐBTBRºÍC57СÊóµÄÔ¤´¦Öóͷ££¬°üÀ¨×ܾàÀ롢ת½Ç×ܾàÀë¡¢ÖÐÐÄÔ˶¯×ÜÊýºÍת½ÇÔ˶¯×ÜÊý¡£C.ÓÃ×ܾàÀ롢ת½Ç×ܾàÀë¡¢ÖÐÐÄ×ÜÒÆ¶¯´ÎÊý¡¢×ª½Ç×ÜÒÆ¶¯´ÎÊýÌåÏֵĿõ³¡ÊÔÑéÏßÐÎͼ¡£D.Ã÷°µÏäÊÔÑ鼯»®¡£E.Ã÷°µÏä²âÊÔ½¹ÂǺÍ̽Ë÷ÐÔ²âÊÔµÄÕÛÏßͼÓÃÃ÷Ïäʱ¼äºÍ¹âÔ˶¯×ÜÊýÌåÏÖ¡£Êý¾ÝÒÔmean¡ÀSEAÌåÏÖ¡£Ã¿×éN = 12¡£ÓëC57-veh×éÏà±È£¬?p < 0.05; ??p < 0.01; ???p < 0.001; ????p < 0.0001;ÓëBTBR-veh×éÏà±È£¬ #p < 0.05; ##p < 0.01¡£×éÄÚ¼°×é¼ä½ÏÁ¿½ÓÄÉTukeyÒªÁì¾ÙÐз½²îÆÊÎö¡£

undefined

£¨Í¼2£©

 

      ͼ2£¬È˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁÆ¿ÉÒÔ¸ÄÉÆBTBRСÊóÔÚÉ罻ʹÃüÖеÄÉ罻ȱÏÝ¡£A.Éç»á»¥¶¯Ê¹Ãü¼Æ»®¡£B. BTBRºÍC57СÊóÔÚÉç»á»¥¶¯Ê¹ÃüÖеÄÔ¤´¦Öóͷ££¬°üÀ¨¿¿½ü´ÎÊý¡¢¿¿½üʱ¼ä¡¢¿¿½üºÍ×·Ëæ´ÎÊý¡¢¿¿½üºÍ×·ËæÊ±¼äµÄÕÛÏßͼ¡£Éç»á»¥¶¯²âÊÔÌåÏÖΪ¿¿½üʱ¼ä£¬¿¿½üʱ¼ä£¬¿¿½üºÍ×·ËæÊ±¼ä£¬¿¿½üºÍ×·ËæÊ±¼ä¡£Êý¾ÝÒÔmean¡ÀSEAÌåÏÖ¡£Ã¿×éN = 12¡£ÓëC57-veh×éÏà±È£¬ ?p < 0.05; ???p < 0.001; ????p < 0.0001; ÓëBTBR-veh×éÏà±È£¬#p < 0.05; ##p < 0.01 ¡£×éÄÚ¼°×é¼ä½ÏÁ¿½ÓÄÉTukeyÒªÁì¾ÙÐз½²îÆÊÎö¡£

undefined

£¨Í¼3£©

 

      ͼ3£¬È˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁƶÔÕü¾ÈÈÏÖªÓ°ÏóȱÏݺ͸ıä¿Ì°åÐÐΪµÄÓ°Ïì¡£A.ÐÂÎïʶ±ð¼Æ»®¡£B.Ô¤´¦Öóͷ£¸÷×éСÊóµÄʶ±ðÖ¸Êý¡£C.¸÷×éСÊóÔ¤´¦Öóͷ£Æ«ºÃÖ¸Êý¡£ÐÂÄ¿µÄʶ±ðµÄÏßÐÎͼÌåÏÖΪ¡£D .ʶ±ðÖ¸ÊýºÍ E.Æ«ºÃÖ¸Êý¡£F.ÖÎÁÆÇ°C57ºÍBTBRСÊóµÄ¿Ì°åÐÐΪһÁ¬Ê±¼ä¡£G. ÿ¸ö²âÊÔʱ¼äµãC57ºÍBTBRСÊóµÄ¿Ì°åÐÐΪһÁ¬Ê±¼ä¡£H. C57ºÍBTBRСÊóƤë״̬¡£I. C57ºÍBTBRСÊóƤë״̬ÆÀ·Ö¡£Êý¾ÝÒÔmean¡ÀSEAÌåÏÖ¡£Ã¿×éN = 12¡£ÓëC57-veh×éÏà±È£¬?p < 0.05; ???p < 0.001; ????p < 0.0001; ÓëBTBR-veh×éÏà±È£¬#p < 0.05; ##p < 0.01 ¡£×éÄÚ¼°×é¼ä½ÏÁ¿½ÓÄÉTukeyÒªÁì¾ÙÐз½²îÆÊÎö¡£


      ͨ¹ýÔÚ²î±ðÒ»Á¬Ê±¼äµã¾ÙÐÐ16s rDNA²âÐò£¬¿ÉÒÔ¿´µ½³¦µÀ¾úȺµÄµ÷½â¡£ÖµµÃ×¢ÖØµÄÊÇ£¬È˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁÆÀֳɵؾÀÕýÁËBTBRСÊóÖÐ΢ÉúÎïȺµÄÏà¶ÔƷòʧµ÷£¬²¢È·¶¨ÁËÌØ¶¨µÄ·Ö½âÀàȺ£¨Í¼4¡¢5£©¡£

undefined

£¨Í¼4£©

 

      ͼ4£¬È˹ÇËè¼ä³äÖʸÉϸ°û£¨hBMMSC£©ÖÎÁƸıäÁË×Ô±ÕÖ¢Ïà¹ØµÄ΢ÉúÎïȺʧµ÷¡£A.Èý¸öÀàȺÔÚ²î±ðʱ¼äµãµÄÃÅ·ÖÀàˮƽÖù״ͼ£¬ÓëC57-veh×é½ÏÁ¿£¬??p < 0.01, ???p < 0.001£»ÓëBTBR-veh×éÏà±È£¬#p < 0.05, ##p < 0.01¡£ºñ±Ú¾úÃÅ/Äâ¸Ë¾úÃűÈÖµµÄWilcoxonÖȺÍÄ¥Á·¡£B. C57ºÍBTBRСÊóÄâ¸Ë¾úÃźͺñ±Ú¾úÃŵį½¾ùƷò(%)¡£

undefined

£¨Í¼5£©

 

      ͼ5£¬spearmanÏà¹Ø¾ØÕóÏÔʾÕý(ºìÉ«)ºÍ¸º(À¶É«)Ïà¹Ø¡£?p < 0.05, ??p < 0.01, ???p < 0.001¡£

 

   ¡¶Life Sciences¡·ÊÇÒ»±¾ÒÔҽҩѧ×ÛºÏÑо¿ÎªÌØÉ«µÄSCI¹ú¼ÊÆÚ¿¯£¬×îÐÂÓ°ÏìÒò×Ó6.1·Ö¡£±¾´ÎSCIÂÛÎĵÄÀֳɽÒÏþ£¬³ä·ÖÕÃÏÔÁ˱ÒÓιú¼Ê¹ÙÍøÃÀ¿ÆÔÚ×Ô±ÕÖ¢ÁÙ´²¿ÆÑÐ×ÔÖ÷Á¢Òì·½ÃæµÄʵÁ¦¡£²»µ½Ò»ÄêµÄʱ¼ä£¬±ÒÓιú¼Ê¹ÙÍøÃÀ¿ÆÁÙ´²ÍŶÓÒѽÓÁ¬Íê³ÉÁ½ÆªSCIÎÄÕµÄÎüÊÕ½ÒÏþ£¬È¡µÃÁËÀúÊ·ÐÔµÄÐÂÍ»ÆÆ¡£ÕâÊDZÒÓιú¼Ê¹ÙÍøÃÀ¿Æ¸ß¶ÈÖØÊÓ¿ÆÑÐÊÂÇ飬ÒÔ¿ÆÑÐÁ¢ÒìµãȼÆóÒµÉú³¤ÒýÇæ£¬Ò»Á¬¼Ó´ó¸Éϸ°û²úÆ·Ñз¢Í¶È룬º»ÊµÆóÒµÉú³¤»ù±¾µÄÖ÷ÒªÌåÏÖ£¬Í¬Ê±Ò²´ú±í×űÒÓιú¼Ê¹ÙÍøÃÀ¿ÆµÄ×Ô±ÕÖ¢×îÐÂÁÙ´²¿ÆÑÐЧ¹ûÊܵ½Á˹ú¼ÊȨÍþѧÊõ½çµÄ¸ß¶È¹Ø×¢ÓëÈϿɡ£

 

×¢£º±¾ÎÄͼƬȪԴÓÚ¡¶Life Sciences¡·ÆÚ¿¯


ÍøÕ¾µØÍ¼